#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1280	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2257	121.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1449	1449	C	137	C	100	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	1280	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2257	121.7	0	HET	.	.	.	A69G	.	69	69	A	334	334	A	128	A,G	63,19	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2518	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3442	154.0	0	.	n	.	0	T695C	SNP	695	695	T	984	984	C	164	C	108	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2518	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3442	154.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1626	1626	A	198	A	143	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2518	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3442	154.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2260	2260	C	189	C	116	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2518	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3442	154.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2334	2334	A	224	A	135	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	2518	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3442	154.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2886	2886	C	125	C,T	71,18	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	104	folP	855	855	100.0	folP.l15.c4.ctg.1	1569	13.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1143	1145	AGC	9;9;9	A;G;C	6;6;6	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	5	230	gyrA	2751	720	100.0	gyrA.l6.c4.ctg.1	1042	7.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	5	230	gyrA	2751	2091	99.81	gyrA.l6.c4.ctg.2	2191	16.9	1	SNP	p	S91F	1	.	.	271	273	TTC	370	372	TTC	27;27;27	T;T;C	18;17;18	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	5	230	gyrA	2751	2091	99.81	gyrA.l6.c4.ctg.2	2191	16.9	1	SNP	p	D95G	1	.	.	283	285	GGC	382	384	GGC	26;26;26	G;G;C	17;17;17	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	5	230	gyrA	2751	2091	99.81	gyrA.l6.c4.ctg.2	2191	16.9	1	SNP	p	G95N	0	.	.	283	285	GGC	382	384	GGC	26;26;26	G;G;C	17;17;17	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	74	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1194	13.9	1	SNP	p	G45D	0	.	.	133	135	GGC	490	492	GGC	40;40;40	G;G;C	25;25;24	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	76	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	541	25.3	0	.	n	.	0	A197.	DEL	197	197	A	312	312	A	30	A	21	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	204	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2624	15.9	1	SNP	p	D86N	0	.	.	256	258	GAC	560	562	GAC	21;21;21	G;A,C;C	13;12,1;14	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	204	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2624	15.9	1	SNP	p	R87W	0	.	.	259	261	CGT	563	565	CGT	21;21;21	C;G;T	13;13;14	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	204	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2624	15.9	1	SNP	p	R87I	0	.	.	259	261	CGT	563	565	CGT	21;21;21	C;G;T	13;13;14	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	204	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2624	15.9	1	SNP	p	S87R	1	.	.	259	261	CGT	563	565	CGT	21;21;21	C;G;T	13;13;14	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	204	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2624	15.9	1	SNP	p	S88P	0	.	.	262	264	TCC	566	568	TCC	21;21;21	T;C,A;C	14;12,1;13	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	0	.	p	.	0	D71V	NONSYN	211	213	GAC	194	196	GTC	14;14;14	G;T,A;C	7;0,7;6	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	0	.	p	.	0	V89A	NONSYN	265	267	GTC	248	250	GCC	14;12;12	G;C,T;C	9;0,7;8	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	0	.	p	.	0	T94P	NONSYN	280	282	ACC	263	265	CCC	10;10;10	C,A;C;C	2,6;8;8	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	0	.	p	.	0	G115D	NONSYN	343	345	GGC	326	328	GAC	9;8;8	G;A,G;C	7;0,6;6	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	0	.	p	.	0	H257L	NONSYN	769	771	CAC	752	754	CTC	20;20;20	C;T,A;C	13;0,13;13	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	0	.	p	.	0	G416R	NONSYN	1246	1248	GGT	1229	1231	CGT	10;13;13	C,G;G;T,G	0,7;9;7,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	528	126	parE	1986	1479	99.53	parE.l6.c30.ctg.1	1479	12.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1211	1213	GGC	8;8;8	G;G;C	4;4;4	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	0	.	p	.	0	V506F	NONSYN	1516	1518	GTC	1869	1871	TTC	4;4;4	T,G;T,G;C	3,1;2,2;3	.	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1284	1286	GCA	18;18;18	G;C;A	11;10;11	penA.5.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1287	1289	ATC	18;18;18	A;T;C	10;11;11	penA.5.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1299	1301	GTG	17;17;17	G;T;G	11;11;11	penA.5.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1299	1301	GTG	17;17;17	G;T;G	11;11;11	penA.5.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1803	1805	ACC	12;12;12	A;C;C	8;8;9	penA.5.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1857	1859	GCG	5;4;4	G;C;G	3;2;3	penA.5.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1857	1859	GCG	5;4;4	G;C;G	3;2;3	penA.5.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1980	1982	AGC	19;19;19	A;G;C	12;12;12	penA.5.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1989	1991	GGC	15;15;15	G;G;C	10;10;10	penA.5.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.001	penA.5.001	1	1	539	182	penA	1752	1752	99.94	penA.l15.c4.ctg.1	2242	16.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2007	2009	CCG	18;18;18	C;C;G,C	12;11;10,2	penA.5.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	392	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3232	25.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1523	1525	CCG	29;29;29	C;C,G;G,C	20;20,1;18,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	126	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2068	12.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	537	537	C	4	C	2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	H217N	NONSYN	649	651	CAT	362	364	AAT	1;1;1	A;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	D218N	NONSYN	652	654	GAT	365	367	AAT	1;2;2	A;A;T	1;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	V226A	NONSYN	676	678	GTA	389	391	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	.	MULTIPLE	700	702	ACT	412	414	GTA	1;1;1	G;T;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	S236N	NONSYN	706	708	AGC	418	420	AAC	1;1;1	A;A;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	N237M	NONSYN	709	711	AAC	421	423	ATG	1;1;1	A;T;G	1;1;0	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	10	porB1a	984	279	90.46	porB1a.l6.c30.ctg.1	616	2.0	0	.	p	.	0	D238fs	FSHIFT	712	712	G	424	424	G	1	G	1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	142	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1596	18.3	0	.	p	.	0	R40L	NONSYN	118	120	CGG	395	397	CTG	7;7;7	C;T;G	4;4;4	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	142	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1596	18.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	908	908	T	20	T	14	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	142	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1596	18.3	1	SNP	p	G120K	0	.	.	358	360	GGT	635	637	GGT	12;12;12	G;G;T,G	8;8;7,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	142	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1596	18.3	1	SNP	p	A121N	0	.	.	361	363	GCC	638	640	GCC	12;12;12	G;C;C	7;8;8	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	142	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1596	18.3	1	SNP	p	A121D	0	.	.	361	363	GCC	638	640	GCC	12;12;12	G;C;C	7;8;8	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	560	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4898	24.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	34	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	864	6.2	1	SNP	p	V57M	1	.	.	169	171	ATG	203	205	ATG	6;6;6	A;T;G	4;4;4	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
